Next step for Xenome
25 September, 2008 by Staff WritersXenome starts Phase II for acute post-operative pain
No alternative for Phosphagenics
24 September, 2008 by Dylan Bushell-EmblingPhosphagenics to delist from AIM, starts Phase I for delivery system
Bridge crossed by HeartWare
23 September, 2008 by Dylan Bushell-EmblingHeartWare gets FDA approval for investigational device
Antibody inflames Arana
23 September, 2008 by Dylan Bushell-EmblingArana develops new anti-inflammatory antibody candidate, prepares for clinic
More light for Clinuvel
23 September, 2008 by Dylan Bushell-EmblingClinuvel to test CUV1657 as adjunct therapy in cancer patients
Day of the iguana
18 September, 2008 by Kate McDonaldANU researchers have discovered a new species of iguana in Fiji
ComBio: Flii and the elephant in the room
18 September, 2008 by Fiona WylieA symposium at ComBio on wound healing promises to take audiences on a journey from basic cell biology right through to 3D skin scaffolds as therapies.
Funds for venture capitalists
18 September, 2008 by Kate McDonaldThree new fund managers selected for Innovation Investment Fund
NuSep licences gels
17 September, 2008 by Dylan Bushell-EmblingNuSep to licence out electrophoresis gels business
ChemGenex raises $12.9m
17 September, 2008 by Dylan Bushell-EmblingMajor shareholders chip in half of capital raising
HeartWare vote for US move
17 September, 2008 by Dylan Bushell-EmblingCourt approves shareholder vote on HeartWare's plans to redomicile
CathRx sells first product to Europe
17 September, 2008 by Dylan Bushell-EmblingDiagnostic modular heart catheters first of several planned for European market
Vascular patent for HealthLinx
17 September, 2008 by Dylan Bushell-EmblingHealthLinx granted US patent for vascular permeability program
